Filling the need for trusted information on national health issues

Sequestration-Related Cuts Affecting CDC’s TB Research Program

In a guest post in the Center for Global Health Policy’s “Science Speaks” blog, Coco Jervis, senior U.S. and global policy associate at the Treatment Action Group, examines how sequestration-related cuts are threatening the CDC’s Tuberculosis Trials Consortium, “the leading TB clinical research collaborative in the world,” she says. “Several TBTC sites have already been cut — and more may follow — hampering the TBTC’s ability to enroll patients into trials, narrowing the scope of research, and resulting in a loss of expertise,” she notes, adding, “Reaching the goal of zero TB deaths is well within our reach, but requires greater commitment by the Obama administration and Congress to support strong, sustained investment in new scientific advances to treat, diagnose, and prevent TB. Restoring funding for the TBTC is vital to stemming the TB epidemic and saving the lives of the millions affected by this disease” (6/27).